P3‐220: Age‐dependent disruption in hippocampal theta oscillation in APP/PS1 mice
Mihály Hajós(Pfizer (United States)), Éva Hajós‐Korcsok(Pfizer (United States)), Elie Needle(Pfizer (United States)), David Riddell(Eli Lilly (United States)), Warren D. Hirst(Pfizer (United States)), Anthony J. Milici(Nationwide Children's Hospital), Chester J. Siok(Pfizer (United States)), Kevin Atchison(Merck & Co., Inc., Rahway, NJ, USA (United States)), Thomas T. Kawabe(Pfizer (United States)), Tamás Kiss(Pfizer (United States)), Brian D. Harvey(Pfizer (United States)), Jianlin Feng(Montreal Heart Institute), Liam Scott(Pfizer (United States))
Cited by 0
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
|Nature Medicine|2020|445
Effects of Experimental Heart Failure on Atrial Cellular and Ionic Electrophysiology
|Circulation|2000|373
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
|Journal of Neuroscience|2008|351